Literature DB >> 12379723

Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice.

Bruce A Vallance1, Wanyin Deng, Myriam De Grado, Crystal Chan, Kevan Jacobson, B Brett Finlay.   

Abstract

Citrobacter rodentium belongs to the attaching and effacing family of enteric bacterial pathogens that includes both enteropathogenic and enterohemorrhagic Escherichia coli. These bacteria infect their hosts by colonizing the intestinal mucosal surface and intimately attaching to underlying epithelial cells. The abilities of these pathogens to exploit the cytoskeleton and signaling pathways of host cells are well documented, but their interactions with the host's antimicrobial defenses, such as inducible nitric oxide synthase (iNOS), are poorly understood. To address this issue, we infected mice with C. rodentium and found that iNOS mRNA expression in the colon significantly increased during infection. Immunostaining identified epithelial cells as the major source for immunoreactive iNOS. Finding that nitric oxide (NO) donors were bacteriostatic for C. rodentium in vitro, we examined whether iNOS expression contributed to host defense by infecting iNOS-deficient mice. Loss of iNOS expression caused a small but significant delay in bacterial clearance without affecting tissue pathology. Finally, immunofluorescence staining was used to determine if iNOS expression was localized to infected cells by staining for the C. rodentium virulence factor, translocated intimin receptor (Tir), as well as iNOS. Interestingly, while more than 85% of uninfected epithelial cells expressed iNOS, fewer than 15% of infected (Tir-positive) cells expressed detectable iNOS. These results demonstrate that both iNOS and intestinal epithelial cells play an active role in host defense during C. rodentium infection. However, the selective expression of iNOS by uninfected but not infected cells suggests that this pathogen has developed mechanisms to locally limit its exposure to host-derived NO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379723      PMCID: PMC130393          DOI: 10.1128/IAI.70.11.6424-6435.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

Review 1.  Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.

Authors:  G Frankel; A D Phillips; I Rosenshine; G Dougan; J B Kaper; S Knutton
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

2.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.

Authors:  S Fu; K S Ramanujam; A Wong; G T Fantry; C B Drachenberg; S P James; S J Meltzer; K T Wilson
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase.

Authors:  S Asfaha; C J Bell; J L Wallace; W K MacNaughton
Journal:  Am J Physiol       Date:  1999-03

5.  Role of bacterial intimin in colonic hyperplasia and inflammation.

Authors:  L M Higgins; G Frankel; I Connerton; N S Gonçalves; G Dougan; T T MacDonald
Journal:  Science       Date:  1999-07-23       Impact factor: 47.728

6.  Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells.

Authors:  A L Salzman; T Eaves-Pyles; S C Linn; A G Denenberg; C Szabó
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

Review 7.  Enterohemorrhagic Escherichia coli.

Authors:  J B Kaper
Journal:  Curr Opin Microbiol       Date:  1998-02       Impact factor: 7.934

8.  Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis.

Authors:  W K MacNaughton; S S Lowe; K Cushing
Journal:  Am J Physiol       Date:  1998-12

9.  Enteropathogenic Escherichia coli inhibits phagocytosis.

Authors:  D L Goosney; J Celli; B Kenny; B B Finlay
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors.

Authors:  A Abe; U Heczko; R G Hegele; B Brett Finlay
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  40 in total

1.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  The commensal microbiota exacerbate infectious colitis in stressor-exposed mice.

Authors:  Jeffrey D Galley; Nicola M Parry; Brian M M Ahmer; James G Fox; Michael T Bailey
Journal:  Brain Behav Immun       Date:  2016-09-12       Impact factor: 7.217

4.  Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.

Authors:  Andrew J McDermott; Charles R Frank; Nicole R Falkowski; Roderick A McDonald; Vincent B Young; Gary B Huffnagle
Journal:  Gut Microbes       Date:  2014-07-21

Review 5.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.

Authors:  Sara M Dann; Martina E Spehlmann; Dustin C Hammond; Mitsutoshi Iimura; Koji Hase; Lillian J Choi; Elaine Hanson; Lars Eckmann
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.

Authors:  Megan E McBee; Yu Zeng; Nicola Parry; Cathryn R Nagler; Steven R Tannenbaum; David B Schauer
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.